“Science and Technology Innovation Board Daily”, May 23 — The main contents of today's Science and Technology Innovation Board Evening Report include: Xinguang Optoelectronics: plans to transfer 12.5% of the shares of the holding subsidiary Zhongjiu Xinguang; Warner Pharmaceuticals: plans to pledge 17.9767% of Heyi Vision's investment with no more than 40 million yuan; Yifei Laser: plans to acquire 51% of Xinjuli's shares for 30 million yuan.

[Focus on hot topics]

Newsletters:

Beijing: Deploying “nuclear explosion point” projects in cutting-edge technology fields such as cell-gene therapy, brain-computer interface, and synthetic biology

The General Office of the Beijing Municipal People's Government issued the “Beijing Action Plan to Accelerate Collaborative Innovation in Medicine and Health (2024-2026)” to accelerate the output of major achievements in life science. Deploying “nuclear explosion point” projects in cutting-edge technology fields such as cell-gene therapy, brain-computer interface, and synthetic biology, has spawned disruptive and leading scientific discoveries and technological breakthroughs. Support basic research on major forward-looking scientific issues such as analysis of brain cognitive principles and mechanisms of aging; lay out applied basic research for reproductive health diseases, difficult and rare diseases; and strengthen research on key core technologies urgently needed in industries such as gene editing.

Is China considering imposing tariffs on imported cars with large emissions or 2.5 liters or more? Ministry of Commerce responds

The Ministry of Commerce held a regular press conference on the afternoon of May 23. Some media asked: There are reports that China is considering imposing tariffs on imported cars with large emissions or 2.5 liters or more to retaliate against European and American restrictions on Chinese automobile exports. Can you confirm whether this is true? Is China considering increasing the tariff rate?

In response, Ministry of Commerce spokesman He Yadong said that we have taken note of the relevant reports. China has firmly followed the path of green and low-carbon development, and has always encouraged and supported the transformation and upgrading of various industries in the direction of green and low-carbon development to achieve high-quality development. Experts in various fields, including the automotive industry, are also conducting research on this to make suggestions and suggestions for dealing with global climate change.

What I want to emphasize is that at present, individual countries and regions have introduced some restrictions in the field of new energy vehicles, which deviate from the concept of green development, violate market economy principles and WTO rules. We believe that these measures will only harm the interests of domestic consumers and affect the global green transformation and efforts to combat climate change.

Qinghai included 9 assisted reproduction programs in the scope of medical insurance reimbursement

According to the Qinghai Provincial Medical Security Bureau, in order to further optimize the maternity support policy, Qinghai included nine assisted reproduction programs in the scope of medical insurance reimbursement to reduce the burden of medical expenses related to childbirth for insured people. According to reports, on the basis of fully considering the affordability of health insurance funds, Qinghai included nine assisted reproduction programs, including egg retrieval, embryo cultivation, and embryo transfer, in the scope of medical insurance reimbursement to reasonably determine service prices. When insured personnel carry out treatment with assisted reproduction programs at outpatient clinics, employees' basic medical insurance and basic medical insurance for urban and rural residents are all reimbursed at a rate of 50%, with no threshold or maximum payment limit.

Tesla's Shanghai Energy Storage Gigafactory officially starts construction today and is expected to be put into operation in the first quarter of 2025

This afternoon, Tesla's Shanghai Energy Storage Gigafactory in the Lingang New Area of Shanghai officially started construction. It is expected to be put into operation in the first quarter of 2025. After commissioning, the Megapack, a large-scale electrochemical commercial energy storage system, will produce 10,000 units, with an energy storage scale of nearly 40 gigawatt-hours (1 gigawatt-hour = 1,000 megawatt-hours). According to reports, this is Tesla's first energy storage gigafactory outside the mainland of the US. It is also another large-scale investment project in China in the ten years since Tesla entered China, following the Shanghai Gigafactory. In 2019, Tesla's Shanghai Gigafactory achieved “construction started in the same year, put into operation that year, and delivery that year” in Lingang. The Shanghai Energy Storage Gigafactory negotiations only took 1 month to sign the contract, once again refreshing the “speed of Lingang”. Tesla's Shanghai Gigafactory already has the capacity to produce more than 950,000 pure electric vehicles per year, and is an important production base and export center for Tesla in the world.

The price of memory chips has increased by about 50% compared to the same period last year, reports say it may continue to rise

Memory chips are the most important segment of the semiconductor market, mainly divided into flash memory and memory. The data shows that since this year, the price of memory chips has increased by about 50% compared to the same period last year. The head of a storage company said that starting at the end of 2023, the semiconductor storage industry has gradually entered an upward cycle, and it has received several notifications from upstream memory chip manufacturers to raise contract prices this year. According to some reports, the price of memory chips may continue to rise. The contract price for new DRAM memory products is expected to rise 13% to 18% in the second quarter of this year.

Depth:

Where is the “nuclear flashpoint” of medical innovation? The Beijing document points to three directions: synthetic biology, gene therapy, and brain-computer interface

Another semiconductor company went bankrupt and liquidated: the mastermind behind the 10 billion project's abortion may have a real estate background

Has the electromagnetic shielding concept won many ups and downs, and Nvidia became an A-share theme engine?

[Science and Technology Innovation Board Company]

Youfang Technology: Terminate the issuance of A-shares to specific targets in 2023

Youfang Technology announced that it received the Shanghai Stock Exchange's “Decision on Terminating the Audit of Shenzhen Youfang Technology Co., Ltd.'s Issuance of Shares to Specific Targets” on May 22, and the Shanghai Stock Exchange decided to terminate the review of the company's issuance of shares to specific targets.

Xinguang Optoelectronics: Plans to transfer 12.5% of the shares of the holding subsidiary Zhongjiu Xinguang

Xinguang Optoelectronics announced that the company plans to transfer 12.5% of the shares of the company's holding subsidiary Sichuan Zhongjiu Xinguang Technology Co., Ltd. to Mianyang Zhongjiu Optoelectronics Technology Co., Ltd., with a transaction amount of 1,654 million yuan. After the transaction is completed, the company's shareholding ratio was changed from 51% to 38.5%, and Zhongjiu Xinguang will no longer be included in the scope of the company's consolidated statements.

Xi Diwei: Ningbo Hongjing plans to reduce the company's shares by no more than 2%

Xi Diwei announced that the shareholder Hongjing Equity Investment Partnership (Limited Partnership) (“Ningbo Hongjing”) of the Meishan Bonded Port Area of Ningbo plans to reduce the total holdings of the company's shares by no more than 8.195 million shares through centralized bidding and bulk transactions, accounting for 2% of the company's total share capital.

Warner Pharmaceuticals: Plans to subscribe for 17.9767% of Heyi Vision's investment of no more than 40 million yuan

Warner Pharmaceuticals announced that it plans to use its own funds to pledge an investment of no more than RMB 40 million and to pledge 17.9767% of Heyi Vision's investment amount.

Yifei Laser: Plans to acquire 51% of Xinjuli's shares for 30 million yuan

Yifei Laser announced that the company plans to use its own capital of RMB 30 million to purchase 51% of the shares of Wuxi Xinjuli Technology Co., Ltd. held by Zhao Laigen. Xinjuli is an EPC-level smart logistics system solution service provider integrating planning and design, software development, digital twins, equipment manufacturing, engineering implementation, and after-sales service.

Maiwei Biotech: 9MW2821 showed outstanding therapeutic efficacy and safety in phase I/II clinical studies of various advanced solid tumors

Maiwei Biotech announced that the company's new antibody-conjugated drug 9mW2821 targeting nectin-4 will report its phase I/II clinical research data and latest developments for various advanced solid tumors in the form of an oral report at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. 9MW2821 is the first domestic company to conduct clinical trials among same-target drugs. It is also the first same-target drug in the world to disclose clinical efficacy data for cervical cancer, esophageal cancer, and breast cancer indications. Current clinical research results have shown outstanding efficacy and safety of treatment.

Bozhong Seiko: Proposed implementation of a restricted stock incentive plan for incentive recipients

Bozhong Precision announced that the company has drawn up the “2024 Restricted Stock Incentive Plan (Draft)” and its summary to implement the restricted stock incentive plan for incentive recipients.

[Venture capital weather vane]

Yunshan Power completed financing of nearly 100 million yuan to accelerate mass production of 46 series supercharged batteries

Yunshan Power (Ningbo) Co., Ltd. announced that it has successively completed the Angel Round and Pre-A round of financing totaling nearly 100 million yuan. The Angel Round was led by Shunwei Capital and followed by Fenglin Capital; the Pre-A round was led by Linge Venture Capital, followed by Ningbo Haishu Industrial Investment and Langrun Capital, and the old shareholder Shunwei continued to increase its capital. According to reports, this round of financing will mainly be used for the construction of the first domestic mass production line for 46 series large cylindrical supercharged batteries.

Xiwei Technology completed an A+ round of financing of 100 million yuan, led by Yiling Capital and Junshan Investment

Xiwei Technology recently completed an A+ round of financing of 100 million yuan, led by Yiling Capital and Junshan Investment. Xiwei Technology is a semiconductor IoT chip solution provider, focusing on the development and innovation of wireless communication chips. The company's first Wi-Fi 6 chip product has passed WFA certification and is suitable for the consumer electronics market and the security IoT market. This round of financing will be used for further R&D and market expansion.

Intelligent Robotics completes $30 million Pre-B round financing

Recently, Jianzhi Robotics completed a pre-B round of financing of 30 million US dollars. The investors in this round are Yizhuang SDIC and Horizon Robotics. The intelligent robot is centered on visual 3D understanding. Through multi-sensor feature level front fusion, it can sense and understand the autonomous vehicle environment without much detail in a multi-dimensional space. Currently, mass production solutions and related products for L2/L2+ advanced assisted driving have been launched.